Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.
about
Gene expression profiling of epithelial ovarian tumours correlated with malignant potentialUltrasensitization: switch-like regulation of cellular signaling by transcriptional inductionTSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity.p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in TaiwanConvergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosisASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growthNovel interactions between actin and the proteasome revealed by complex haploinsufficiencyDEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transitionVoting-based cancer module identification by combining topological and data-driven propertiesIdentification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data.Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China.ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphismFrameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiencyRecurrent hemizygous deletions in cancers may optimize proliferative potentialHemizygosity for Atm and Brca1 influence the balance between cell transformation and apoptosis.Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma.Haploinsufficiency and the sex chromosomes from yeasts to humans.Linking genetics to structural biology: complex heterozygosity screening with actin alanine scan alleles identifies functionally related surfaces on yeast actin.Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer.VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancerNKX3.1 is regulated by protein kinase CK2 in prostate tumor cellsA Drosophila model of multiple endocrine neoplasia type 2.High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping.Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotypeMutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.Combined haploinsufficiency and genetic control of the G2/M checkpoint in irradiated cells.Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.Differential Sensitivity of Target Genes to Translational Repression by miR-17~92.Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypesCarcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism.Dominance from the perspective of gene-gene and gene-chemical interactionsSTOP gene Phactr4 is a tumor suppressorProgrammed genetic instability: a tumor-permissive mechanism for maintaining the evolvability of higher species through methylation-dependent mutation of DNA repair genes in the male germ line.Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- miceAccelerated geroncogenesis in hereditary breast-ovarian cancer syndromeA comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH.Dicer1 functions as a haploinsufficient tumor suppressor.
P2860
Q24805553-8BEB7BB3-1196-40BC-9680-F439134BCC3BQ24811827-293928B7-2147-4E48-91FD-EDDD5B1E99B4Q27851543-91CF12E6-6A15-4FB7-9D39-D33459364488Q28384167-D8AC580A-2885-474E-950C-E616233FAB74Q28472991-54861588-C9B1-45BF-84D4-FFFFD0FA3CEAQ28509641-41C2EAB1-455E-4E20-9A4F-30B1EA265BFAQ30430569-902A5EAC-03AF-45B4-93E7-94D72B1FE0E7Q30584686-5860B436-406F-492C-9F92-394A5AF3C093Q30661179-543C5820-8C97-42B2-BB50-CEAA48D048DFQ31142505-9BC290F9-D8A1-481A-B18A-AF3A51A40978Q33289807-308AA0EC-CCF2-4AE1-A0A3-2F3571131220Q33328665-FBB6434C-DD62-4CF5-AC0B-5792F6A9ED52Q33383621-DDEB83D9-0D5A-45F0-A6E9-A5018EA33095Q33544002-FD62D807-A751-4AEF-9603-D0BE504B9431Q33637152-C3F8B019-A1D6-42B6-8840-1ED087C31A67Q33711869-66B91436-40CA-4892-9C8B-72DE60212FDBQ33772264-C85DD04F-5174-4684-80BC-EE89DA5C3D9FQ33830992-91191842-3535-4675-A373-0201B80BB272Q34042411-E22D21BE-6706-4204-9D61-DD5D2DF1F896Q34139499-B0353241-6D3C-46A6-9AD3-A3FDBE9957DCQ34328133-7776C7B4-D7E3-4548-BA22-E6227DE155D1Q34563193-0B41A6D7-D5C6-4426-9646-D5C094FCD443Q34589821-845BE951-5FA0-40DE-8946-2E701703903AQ35012994-9EED57AE-96AF-4A93-9353-CB1D8BEDAF1FQ35230221-933053ED-F739-46B8-8BD1-C2886A6E430CQ35249211-1F5C9C6E-70F6-4CA9-A449-33582A0AB6E5Q35470405-D1E083F9-3288-4DB4-AA88-FAC8296E6C65Q36107116-1FC6C4AB-CC84-4A5C-9857-C591E444C003Q36190022-E76B36F3-D9EE-426C-9B49-918750404A1AQ36274109-63EE5F14-EC6F-49D4-BE54-9C2EEFD7B631Q36291392-90D28D4A-AECD-4F52-86F2-960F2302AFCCQ36413155-585E1083-5122-4D04-ADF9-BF0075C978F8Q36564307-540B8196-D2F9-4C0B-8E92-5F4074F2CAAAQ36564341-A1C35C3C-D30A-4C90-8F7A-AE657035AD15Q36583230-D4BDE2ED-D834-4415-BD85-BF40E569C3A4Q36766892-29C02E3A-BF5F-4C96-A71C-C1E1CAC14D33Q36787334-990E8415-AF45-4C68-9616-8647CCC1D22AQ37022075-C8721FB8-0997-49C3-B6AB-44E85B17B5A9Q37205060-3AB31D88-B9E4-452A-820F-67018DA2A564Q37457958-1396FAEF-A33C-4B58-AFA3-6DFD35C811C5
P2860
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.
@ast
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.
@en
type
label
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.
@ast
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.
@en
prefLabel
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.
@ast
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.
@en
P1476
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.
@en
P304
P356
10.1016/J.BBCAN.2004.01.001
P407
P577
2004-06-01T00:00:00Z